BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25669981)

  • 1. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP; Kwok TT
    Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatment.
    Sharma P; Singh S
    Integr Cancer Ther; 2020; 19():1534735420911437. PubMed ID: 32248711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer.
    Long XB; Sun GB; Hu S; Liang GT; Wang N; Zhang XH; Cao PP; Zhen HT; Cui YH; Liu Z
    Oncol Rep; 2009 Nov; 22(5):1189-95. PubMed ID: 19787239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
    Müller DW; Bosserhoff AK
    Oncogene; 2008 Nov; 27(52):6698-706. PubMed ID: 18679415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
    Wang M; Hu Y; Amatangelo MD; Stearns ME
    Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
    J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer.
    Wu J; Li S; Jia W; Deng H; Chen K; Zhu L; Yu F; Su F
    PLoS One; 2015; 10(7):e0133643. PubMed ID: 26218285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer.
    Li B; Chen P; Chang Y; Qi J; Fu H; Guo H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):739-45. PubMed ID: 27498032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
    Wang YY; Ren T; Cai YY; He XY
    Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
    Liu K; Zhang C; Li T; Ding Y; Tu T; Zhou F; Qi W; Chen H; Sun X
    Int J Oncol; 2015; 46(6):2526-34. PubMed ID: 25846193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
    Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
    Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let-7a regulation of insulin-like growth factors in breast cancer.
    Lu L; Katsaros D; Zhu Y; Hoffman A; Luca S; Marion CE; Mu L; Risch H; Yu H
    Breast Cancer Res Treat; 2011 Apr; 126(3):687-94. PubMed ID: 20848182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.
    Yang Q; Jie Z; Cao H; Greenlee AR; Yang C; Zou F; Jiang Y
    Carcinogenesis; 2011 May; 32(5):713-22. PubMed ID: 21349817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yangzheng Sanjie decoction regulates proliferation and apoptosis of gastric cancer cells by enhancing let-7a expression.
    Deng HX; Yu YY; Zhou AQ; Zhu JL; Luo LN; Chen WQ; Hu L; Chen GX
    World J Gastroenterol; 2017 Aug; 23(30):5538-5548. PubMed ID: 28852313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.
    El Habre R; Aoun R; Tahtouh R; Hilal G
    BMC Cancer; 2024 May; 24(1):615. PubMed ID: 38773429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
    Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
    Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.